Abstract: The invention relates to a method for producing an at least partially coated object, comprising the step of producing the object from a construction material by means of an additive manufacturing method, the construction material comprising a thermoplastic polyurethane material. Following the production of the object, the method comprises the step of at least partially bringing a preparation into contact with the object, the preparation being selected from: an aqueous polyurethane dispersion; an aqueous dispersion of a polymer comprising OH groups, this dispersion also containing a compound comprising NCO groups; an aqueous preparation of a compound containing NCO groups, but not containing any polymers comprising OH groups; or a combination of at least two thereof. The invention also relates to an at least partially coated object that was obtained by a method according to the invention.

Abstract: A multiplex assay with an improved sensitivity and specificity for the diagnosis of Brucella canis infection in mammals using two specific antigens (BP26 and Omp31pep) is disclosed. Also disclosed are kits for detecting immune responses to a Brucella canis infection, methods of detection, methods for monitoring progression and methods for treating a Brucella canis infection.

Abstract: The present invention provides methods for inducing an immune response to a pathogen in neonatal mammals. In particular, the present invention provides methods for inducing an immune response to a pathogen in a neonatal mammal comprising administering to the neonatal mammal a composition comprising a fusion protein between interleukin-4 (IL-4) and a first antigen of the pathogen.

Abstract: The present disclosure is directed to novel biomarkers useful for staging EHV-1 infections and immunity status of horses. This disclosure is further directed to methods of determining EHV-1 infection stage and immunity status of horses using the novel biomarkers.

Abstract: The present invention provides novel Mycobacterium avium subspecies paratuberculsis (MAP) derived antigens which may be used to diagnose and thereafter effectively treat animals that have been infected with MAP, Further provided are methods of determining whether an animal is infected with MAP, and methods of diagnosing and treating Johne's disease. The invention also relates to a kit for the implementation of the methods.

Abstract: A reamer head for a reamer includes one or more blades separated by flutes. Each flute has a front core region proximate a front end of the cutting portion, a rear portion proximate a rear end of the cutting portion and the middle core region therebetween. The front core region has a thickness, T1, the middle core region has a thickness, T2, and the rear core region has a thickness, T3. The thickness, T2, of the middle core region is greater than the thickness, T1, of the front core region and the thickness, T3, of the rear core region. A method of making the reamer head is also disclosed.

Abstract: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer. The dimer is formed specifically from glycosylated monomers and is used for producing pharmaceutical products with an extended half-life.

Abstract: A serological assay with an improved linear range of detection is disclosed using a fusion protein system, such as an anti-cytokine/cytokine fusion protein (ACYF) system, for evaluating immune responses. Also disclosed are related compositions, fusion proteins, expression vectors, monoclonal antibodies, and kits for practicing the assay method of the present invention.

Abstract: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer.

Abstract: A serological assay with an improved linear range of detection is disclosed using a fusion protein system, such as an anti-cytokine/cytokine fusion protein (ACYF) system, for evaluating immune responses. Also disclosed are related compositions, fusion proteins, expression vectors, monoclonal antibodies, and kits for practicing the assay method of the present invention.

Abstract: The present invention provides methods for inducing an immune response to a pathogen in neonatal mammals. In particular, the present invention provides methods for inducing an immune response to a pathogen in a neonatal mammal comprising administering to the neonatal mammal a composition comprising a fusion protein between interleukin-4 (IL-4) and a first antigen of the pathogen.

Abstract: A method for diagnosing Lyme disease status in a mammal is provided. The method entails, in a biological sample obtained or derived from a mammal, determining antibodies to Borrelia burgdorferi (B. burgdorferi) outer surface proteins (Osp) OspA, OspC, and OspF. Based upon determining the OspA, OspC, and OspF antibodies, the mammal can be diagnosed as vaccinated, not vaccinated, infected or not infected with B. burgdorferi. Mammals that have early, intermediate or chronic B. burgdorferi infection can also be identified. The method is particularly suited for use with horses and dogs. Isolated or recombinant B. burgdorferi antigens and compositions that contain them are also provided.

Abstract: In order to ensure highly precise setting, in particular readjustment of the radial position of the blade in the case of a rotary tool, in particular a reamer, an adjustment element, in particular in the form of an adjustment screw, having a cone formed by the screw head is inserted into an end-side receptacle in a cutting section, said cone being provided with a friction-reducing coating.

Abstract: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer.

Abstract: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer. The dimer is formed specifically from glycosylated monomers and is used for producing pharmaceutical products with an extended half-life.

Abstract: A method for diagnosing Lyme disease status in a mammal is provided. The method entails, in a biological sample obtained or derived from a mammal, determining antibodies to Borrelia burgdorferi (B. burgdorferi) outer surface proteins (Osp) OspA, OspC, and OspF. Based upon determining the OspA, OspC, and OspF antibodies, the mammal can be diagnosed as vaccinated, not vaccinated, infected or not infected with B. burgdorferi. Mammals that have early, intermediate or chronic B. burgdorferi infection can also be identified. The method is particularly suited for use with horses and dogs. Isolated or recombinant B. burgdorferi antigens and compositions that contain them are also provided.

Abstract: This invention provides improved methods for production of monoclonal antibodies against a protein of interest. The present methods are based on immunization of an animal with a fusion protein between a protein of interest and a Th2 cytokine such as IL-4, IL-5, IL-13 and IL-31.

Abstract: The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer. The dimer is formed specifically from glycosylated monomers and is used for producing pharmaceutical products with an extended half-life.

Abstract: The invention relates to novel equine C&egr;?a and C&egr;?b genes coding for IgE-allotypes heavy chain constant regions and used in the production of IgE-isotype recombinant immunoglobulin. Said recombinant immunoglobulins represent valuable auxiliary agents for IgE-diagnosis, especially equine allergy diagnosis. With the aid of the recombinant IgEs, antibodies are obtained that can be used in allergy diagnosis, inter alia, in ELISA-based test kits.